BIPROGY (8056) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
20 Oct, 2026Executive summary
Q1 FYMar2025 revenue rose 10.6% YoY to ¥88,352 million, driven by DX investment and product sales.
Operating profit increased 12.8% to ¥6,578 million; adjusted operating profit rose 9.7% to ¥6,326 million.
Profit attributable to owners of parent grew 12.1% to ¥4,892 million.
Revenue grew across all business segments; orders increased 13.5% and year-end revenue backlog rose 6.6%.
Strategic priorities include digital transformation, core business enhancement, and regional and global expansion.
Financial highlights
Gross profit was ¥21,636 million, up from ¥20,402 million YoY; gross margin was 24.5%, down 1.1pt as system-services profit fell and outsourcing costs rose.
SG&A expenses were ¥15.3bn, up 4.6% YoY; operating margin was 7.4%, up 0.1pt.
Basic EPS rose to ¥48.66 from ¥43.44 YoY.
Total assets were ¥296,819 million and equity was ¥168,188 million; cash and cash equivalents were ¥60,961 million, up ¥1,698 million from prior year-end.
Outlook and guidance
FYMar2025 forecast unchanged: revenue ¥385,000 million (+4.0% YoY), operating profit ¥35,500 million (+6.6%) and profit attributable to owners of parent ¥24,500 million (-3.0%).
Full-year gross profit forecast is ¥101.2bn (+4.1%); SG&A expenses ¥66.2bn (+4.5%); operating margin 9.2% versus 9.0% in FYMar2024.
Adjusted operating profit forecast is ¥35.0bn (+3.5%); higher R&D, personnel and internal system costs are partly offset by gross-profit growth.
Annual dividend forecast is ¥100 per share, comprising interim and year-end dividends of ¥50 each; payout ratio is 41.0%.
Latest events from BIPROGY
- Q1 operating profit rose 22% as revenue, orders, and backlog grew.8056
Q1 2024 - H1 revenue rose 11.8% and operating profit 21.9%; FY guidance stayed unchanged.8056
Q2 2024 - Strong DX demand lifted FYMar2024 results; growth investment supports FYMar2025 expansion.8056
Q4 2024 - 9M revenue and operating profit grew; full-year forecasts and dividends rose.8056
Q3 2024 - Deferred product sales cut Q1 profit, while orders surged and FY2027 guidance stayed unchanged.8056
Q1 2027 - Revenue and operating profit rose, but net profit declined; full-year guidance was unchanged.8056
Q2 2025 - Revenue and orders grew, lifting the FY revenue forecast despite lower net profit.8056
Q3 2025 - Revenue and operating profit grew; FY2027 revenue target rose to ¥440bn.8056
Q4 2025 - Q1 revenue and profit grew; full-year guidance remains unchanged.8056
Q1 2026